Randall Rossi
Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Neoplastic Stem Cells | 5 | 2002 | 21 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 1989 | 53 |
Why?
|
Sesquiterpenes | 3 | 2005 | 24 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2007 | 33 |
Why?
|
Leukemia, Myeloid | 2 | 1990 | 37 |
Why?
|
Butyrates | 2 | 1989 | 5 |
Why?
|
Butyric Acids | 2 | 1989 | 8 |
Why?
|
Blast Crisis | 3 | 2005 | 12 |
Why?
|
Mice, SCID | 6 | 2000 | 61 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2010 | 21 |
Why?
|
NF-kappa B | 4 | 2002 | 114 |
Why?
|
Leukemia, Experimental | 1 | 1990 | 20 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2010 | 67 |
Why?
|
Cell Differentiation | 3 | 1987 | 262 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2008 | 4 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2008 | 10 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2008 | 15 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 216 |
Why?
|
Thiadiazoles | 1 | 2007 | 8 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 138 |
Why?
|
Apoptosis | 2 | 2002 | 265 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2008 | 86 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2007 | 26 |
Why?
|
Mice | 10 | 1986 | 623 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2007 | 38 |
Why?
|
Hodgkin Disease | 1 | 2008 | 46 |
Why?
|
Mice, Inbred NOD | 4 | 2000 | 24 |
Why?
|
Protein-Serine-Threonine Kinases | 1 | 2007 | 105 |
Why?
|
Tumor Cells, Cultured | 5 | 1987 | 233 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 121 |
Why?
|
Animals | 10 | 1986 | 1031 |
Why?
|
Signal Transduction | 2 | 2007 | 313 |
Why?
|
Leukocytes | 1 | 2002 | 94 |
Why?
|
Receptors, Interleukin-3 | 1 | 2000 | 3 |
Why?
|
Hematopoietic Stem Cells | 1 | 2002 | 69 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2002 | 82 |
Why?
|
Cell Cycle | 2 | 1990 | 121 |
Why?
|
Stem Cells | 1 | 2000 | 107 |
Why?
|
Humans | 11 | 1987 | 1856 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2002 | 61 |
Why?
|
Disease Models, Animal | 2 | 2007 | 349 |
Why?
|
Butyric Acid | 2 | 1989 | 5 |
Why?
|
Neoplasm Transplantation | 2 | 2002 | 67 |
Why?
|
Cells, Cultured | 2 | 2005 | 447 |
Why?
|
Antineoplastic Agents | 2 | 2005 | 190 |
Why?
|
Ethyl Methanesulfonate | 1 | 1990 | 6 |
Why?
|
Sirolimus | 1 | 2010 | 25 |
Why?
|
Drug Synergism | 1 | 2010 | 104 |
Why?
|
Peroxidase | 1 | 1990 | 27 |
Why?
|
Drug Resistance | 1 | 1990 | 83 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 78 |
Why?
|
Histone Deacetylases | 1 | 1990 | 30 |
Why?
|
Bone Marrow | 1 | 2010 | 109 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 135 |
Why?
|
Deoxycytidine | 1 | 2008 | 20 |
Why?
|
Blotting, Western | 1 | 2010 | 275 |
Why?
|
B-Cell Activating Factor | 1 | 2007 | 8 |
Why?
|
Boronic Acids | 1 | 2008 | 16 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2007 | 5 |
Why?
|
Pyrazines | 1 | 2008 | 20 |
Why?
|
Flow Cytometry | 1 | 2010 | 216 |
Why?
|
Biological Availability | 1 | 2007 | 36 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2007 | 35 |
Why?
|
Tumor Markers, Biological | 1 | 2010 | 112 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 243 |
Why?
|
Drug Design | 1 | 2007 | 33 |
Why?
|
Phenotype | 2 | 1987 | 303 |
Why?
|
Sulfhydryl Compounds | 1 | 2007 | 42 |
Why?
|
Neutrophils | 1 | 1989 | 114 |
Why?
|
Dogs | 1 | 2007 | 159 |
Why?
|
Cell Death | 1 | 2007 | 94 |
Why?
|
Cell Proliferation | 1 | 2010 | 227 |
Why?
|
Structure-Activity Relationship | 1 | 2007 | 124 |
Why?
|
Cell Lineage | 1 | 2007 | 60 |
Why?
|
Benzo(a)pyrene | 1 | 1986 | 7 |
Why?
|
Mice, Transgenic | 1 | 2008 | 209 |
Why?
|
Protein Kinase C | 1 | 2007 | 93 |
Why?
|
Cell Survival | 1 | 2007 | 229 |
Why?
|
Tumor Stem Cell Assay | 1 | 2005 | 21 |
Why?
|
Lactones | 1 | 2005 | 12 |
Why?
|
Leukemia | 1 | 1987 | 70 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 208 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 126 |
Why?
|
Cell Membrane | 1 | 2007 | 170 |
Why?
|
Immune System | 1 | 1986 | 43 |
Why?
|
Transplantation, Heterologous | 1 | 2005 | 57 |
Why?
|
Survival Rate | 1 | 2007 | 250 |
Why?
|
Oxidative Stress | 1 | 2007 | 119 |
Why?
|
Mutation | 1 | 1990 | 340 |
Why?
|
Idarubicin | 1 | 2002 | 4 |
Why?
|
Leupeptins | 1 | 2002 | 14 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2002 | 19 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2002 | 16 |
Why?
|
RNA, Messenger | 1 | 2010 | 394 |
Why?
|
I-kappa B Proteins | 1 | 2002 | 33 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2002 | 35 |
Why?
|
Cysteine Endopeptidases | 1 | 2002 | 41 |
Why?
|
Reactive Oxygen Species | 1 | 2005 | 112 |
Why?
|
Multienzyme Complexes | 1 | 2002 | 45 |
Why?
|
Graft Survival | 1 | 2002 | 74 |
Why?
|
Alleles | 1 | 2002 | 108 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 318 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 189 |
Why?
|
Acute Disease | 1 | 2002 | 271 |
Why?
|
Immunophenotyping | 1 | 2000 | 66 |
Why?
|
Neoplasm Proteins | 1 | 2002 | 110 |
Why?
|
Male | 2 | 2007 | 1553 |
Why?
|
Female | 2 | 2007 | 1643 |
Why?
|
Middle Aged | 1 | 2008 | 1161 |
Why?
|
Adult | 1 | 2008 | 1317 |
Why?
|
Carboxylesterase | 1 | 1989 | 3 |
Why?
|
Antigens, CD15 | 1 | 1989 | 2 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 1989 | 7 |
Why?
|
Antigens, Differentiation | 1 | 1989 | 53 |
Why?
|
Calcitriol | 1 | 1989 | 29 |
Why?
|
Cell Separation | 1 | 1989 | 110 |
Why?
|
Thioguanine | 1 | 1987 | 5 |
Why?
|
Rosette Formation | 1 | 1987 | 13 |
Why?
|
Monocytes | 1 | 1989 | 124 |
Why?
|
Histamine | 1 | 1987 | 17 |
Why?
|
Macrophages | 1 | 1989 | 148 |
Why?
|
Hemolytic Plaque Technique | 1 | 1986 | 6 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1986 | 21 |
Why?
|
Mice, Inbred Strains | 1 | 1986 | 118 |
Why?
|
Antibody Formation | 1 | 1986 | 89 |
Why?
|
Immunosuppressive Agents | 1 | 1986 | 102 |
Why?
|
Lymphocyte Activation | 1 | 1986 | 137 |
Why?
|
Cell Line | 1 | 1987 | 375 |
Why?
|
